United States · 
What does Refactor Capital invest in?
Refactor Capital invests most often at Seed and Series A (68% of the rounds on record), in sectors such as Transcriptomics, Medicines and Cell Therapy.
Refactor Capital highlights
- 01
3 cheques in the last 12 months
- 02
Mostly Seed and Series A: 68% of its rounds
- 03
Sole investor in 1 rounds, median $4.0M
What they do
Refactor is a seed-stage hard tech venture firm. Solo GP Zal Bilimoria writes $1-2M checks into founders building in aerospace, energy, bio, health, nuclear, defense, advanced manufacturing, and critical materials.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $500K – $2.0M as they say
- Stages
- Pre-seedSeedSeries A
- Sectors
- TranscriptomicsMedicinesCell Therapy
- Based in
- Burlingame, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first56 appearances
- 2026
1 round
- Feb
- 2025
12 rounds
- Dec
- Dec
- Oct
- Oct
- Jul
- Jun
- May
- Apr
- Mar
- Mar
- Mar
- Feb
- 2024
8 rounds
- Sept
- Jul
- Jun
- May
- May
- Apr
- Mar
- Feb
- 2023
8 rounds
- Dec
- Nov
- Aug
- Jun
- Apr
- Mar
- Feb
- Jan
- 2022
7 rounds
- Aug
- Jul
- Jun
- May
- May
- Apr
- Mar
- 2021
2 rounds
- Dec
- Oct
- 2019
6 rounds
- Oct
- Sept
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration3 named
DLDavid LeeManaging MemberiFiling they signed
RBRick BarberManageriFiling they signed
ZBZal BilimoriaManaging DirectoriFiling they signed
We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$416Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Refactor Capital Management, LLC
- SEC number
- CRD 308137
What they claim to have backed
From their own portfolio page (on their website)
28 of 49 we have independently watched raise
64-X BioAkasaAstranisAvailBerkeley YeastBiorenderCheckerspotClover HealthCurativeEnzymeFactoryFourFloodbaseGranza BioHeadspaceHexiumKipKnowdeLucyMacro OceansOnyx BioOpheliaParallel BioPathAIPicnic HealthPila EnergyRemedy ScientificSolugenThalo LabsAdventrisAtlasBlockfolioBrelleCausal LabsCoinbaseEpana BioGeneral GalacticHeroInferraLoyalMiistOctantOrchid HealthPhytoformPilgrimTBCTempestUniform TeethVital HealthVitra Labs
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.